REFERENCES
M. G. Wientjes, J. T. Dalton, R. A. Badalament, J. R. Drago, and J. L.-S. Au. Cancer Res. 51:4347–4354 (1991).
T. D. Schmittgen, J. M. Weaver, R. A. Badalament, R. A., M. G. Wientjes, E. Klein, D. Young, D., and J. L.-S. Au. J. Urol. 152:1632–1636 (1994).
M. G. Wientjes, R. A. Badalament, and J. L.-S. Au. Cancer Chemother. Pharmacol. 32:255–262 (1993).
S. R. Keyes, P. M. Fracasso, D. C. Heimbrook, S. Rockwell, S. G. Sligar, and A. C. Sartorelli. Cancer Res. 44:5638–5643 (1984).
R. R. Perry, Y. Kang, and B. Greaves. Biochem. Pharmacol. 46:1999–2005 (1993).
S. Pan, S. A. Akman, G. L. Forrest, C. Hipsher, and R. Johnson. Cancer Chemother. Pharmacol. 31:23–31 (1992).
B. H. Xu, V. Gupta, and S. V. Singh. Int. J. Cancer. 58:686–692 (1994).
B. H. Xu, V. Gupta, and S. V. Singh. Br. J. Cancer. 69:242–246 (1994).
L. Dusre, S. Rajagopalan, H. M. Eliot, J. M. Covey, and B. K. Sinha. Cancer Res. 50:648–652 (1990).
B. H. Xu and S. V. Singh. Cancer Res. 52:6666–6670 (1992).
W. T. Bradner, W. C. Rose, J. E. Schurig, and A. P. Florczyk. Invest. New Drugs. 8:S1–S7 (1990).
Q.-Y. He, H. Maruenda, and M. Tomasz. J. Am. Chem. Soc. 116:9349–9350 (1994).
S. Rockwell, B. Kemple, and M. Kelley. Biochem. Pharmacol. 50:1239–1243 (1995).
C. L. Bregman, R. A. Buroker, W. T. Bradner, R. S. Hirth, and H. Madisson. Fundament. Appl. Toxicol. 13:46–64 (1989).
W. C. Yen, T. Schmittgen, and J. L.-S. Au. Pharm. Res. In press (1996).
R. Hay, J. Caputo, T. R., Chen, M. Macy, P. Mclintock, and Y. Reid. American-Type Culture Collection. 7th ed., 1992.
C. O'Toole. In: Webber, M. M. (ed), In vitro models for cancer research, CRC Press, Vol. IV, 1986, p. 103–125.
P. Skehan, R. Storeng, S. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd. J. Natl. Cancer Inst. 82:1107–1112 (1990).
Y. Gan, M. G. Wientjes, D. E. Schuller, and J. L.-S. Au. Cancer Res. 56:2086–2093 (1996).
N. H. Holford and L. B. Sheiner. Pharmacol. Ther. 16:143–166 (1982).
R. M. Hoffman. Cancer Metast. Rev. 13:169–173 (1994).
P. S. Steeg, M. C. Ally, and M. R. Grever. J. Natl. Cancer Inst. 86:953–955 (1994).
Rights and permissions
About this article
Cite this article
Yen, WC., Au, J.LS. Pharmacodynamic Evaluation of Mitomycin C Analog BMS-181174 for Potential use in Intravesical Bladder Cancer Therapy. Pharm Res 14, 241–245 (1997). https://doi.org/10.1023/A:1012069231506
Issue Date:
DOI: https://doi.org/10.1023/A:1012069231506